Amgen's expenditure on research and development by category 2012-2023

This statistic shows the expenditure on research and development of biotech company Amgen in 2012 to 2023, sorted by category. Amgen is a U.S.-based multinational biopharmaceutical company, headquartered in Thousand Oaks, California. Amgen's R&D expenses amounted to approximately 4.8 billion U.S. dollars in 2023. Of that amount, some 1.9 billion U.S. dollars were spent on later stage clinical programs.